TMEM106B and Alzheimer disease: In neurodegeneration (including Alzheimer’s disease (AD), FTLD-TDP, etc.)the expression of the microRNA132/212 cluster is decreased [18, 25, 50, 56], suggesting an upregulation of TMEM106B expression in disease.